Bååth, M.; Jönsson, J.-M.; Westbom Fremer, S.; MartÃn de la Fuente, L.; Tran, L.; Malander, S.; Kannisto, P.; MÃ¥sbäck, A.; Honeth, G.; Hedenfalk, I.
MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer. Genes 2021, 12, 742.
https://doi.org/10.3390/genes12050742
AMA Style
Bååth M, Jönsson J-M, Westbom Fremer S, MartÃn de la Fuente L, Tran L, Malander S, Kannisto P, MÃ¥sbäck A, Honeth G, Hedenfalk I.
MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer. Genes. 2021; 12(5):742.
https://doi.org/10.3390/genes12050742
Chicago/Turabian Style
Bååth, Maria, Jenny-Maria Jönsson, Sofia Westbom Fremer, Laura MartÃn de la Fuente, Lena Tran, Susanne Malander, Päivi Kannisto, Anna MÃ¥sbäck, Gabriella Honeth, and Ingrid Hedenfalk.
2021. "MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer" Genes 12, no. 5: 742.
https://doi.org/10.3390/genes12050742
APA Style
Bååth, M., Jönsson, J.-M., Westbom Fremer, S., MartÃn de la Fuente, L., Tran, L., Malander, S., Kannisto, P., MÃ¥sbäck, A., Honeth, G., & Hedenfalk, I.
(2021). MET Expression and Cancer Stem Cell Networks Impact Outcome in High-Grade Serous Ovarian Cancer. Genes, 12(5), 742.
https://doi.org/10.3390/genes12050742